[1] M. A. Martinez, “Compounds with therapeutic potential against novel respiratory 2019

coronavirus,” Antimicrobial agents and chemotherapy, vol. 64, no. 5, pp. e00399-20, 2020.

[2] M. Siahaan, “Dampak pandemi Covid-19 terhadap dunia pendidikan,” Dampak Pandemi

Covid-19 Terhadap Dunia Pendidikan, vol. 20, no. 2, 2020.

[3] T.-M. Chen, J. Rui, Q.-P. Wang, Z.-Y. Zhao, J.-A. Cui, and L. Yin, “A mathematical model for

simulating the phase-based transmissibility of a novel coronavirus,” Infectious diseases of

poverty, vol. 9, no. 1, pp. 1–8, 2020.

[4] R. Lu et al., “Genomic characterisation and epidemiology of 2019 novel coronavirus:

implications for virus origins and receptor binding,” The lancet, vol. 395, no. 10224, pp. 565–

574, 2020.

[5] L. T. Phan et al., “Importation and human-to-human transmission of a novel coronavirus in

Vietnam,” New England Journal of Medicine, vol. 382, no. 9, pp. 872–874, 2020.

[6] Z. Xu et al., “Pathological findings of COVID-19 associated with acute respiratory distress

syndrome,” The Lancet respiratory medicine, vol. 8, no. 4, pp. 420–422, 2020.

[7] S. E. Haque and M. Rahman, “Association between temperature, humidity, and COVID-19

outbreaks in Bangladesh,” Environmental science & policy, vol. 114, pp. 253–255, 2020.

[8] A. M. Zaki, S. Van Boheemen, T. M. Bestebroer, A. D. M. E. Osterhaus, and R. A. M.

Fouchier, “Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia,” New

England Journal of Medicine, vol. 367, no. 19, pp. 1814–1820, 2012.

[9] C. Drosten et al., “Identification of a novel coronavirus in patients with severe acute respiratory

syndrome,” New England journal of medicine, vol. 348, no. 20, pp. 1967–1976, 2003.

[10] A. Ghosh, R. Gupta, and A. Misra, “Telemedicine for diabetes care in India during COVID19

pandemic and national lockdown period: guidelines for physicians,” Diabetes & Metabolic

Syndrome: Clinical Research & Reviews, vol. 14, no. 4, pp. 273–276, 2020.

[11] P. Zhou et al., “A pneumonia outbreak associated with a new coronavirus of probable bat

origin,” nature, vol. 579, no. 7798, pp. 270–273, 2020.

[12] N. Zhu et al., “A novel coronavirus from patients with pneumonia in China, 2019,” New

England journal of medicine, 2020.

[13] N. Coronavirus, “Situation Report–22 (World Health Organization, 2020).” 2019.

[14] N. Chen et al., “Epidemiological and clinical characteristics of 99 cases of 2019 novel

coronavirus pneumonia in Wuhan, China: a descriptive study,” The lancet, vol. 395, no. 10223,

pp. 507–513, 2020.

[15] J. F.-W. Chan et al., “A familial cluster of pneumonia associated with the 2019 novel

coronavirus indicating person-to-person transmission: a study of a family cluster,” The lancet,

vol. 395, no. 10223, pp. 514–523, 2020.

[16] W.-R. Zhang, “Bipolar fuzzy sets and relations: a computational framework for cognitive

modeling and multiagent decision analysis,” in NAFIPS/IFIS/NASA’94. Proceedings of the

First International Joint Conference of The North American Fuzzy Information Processing

Society Biannual Conference. The Industrial Fuzzy Control and Intellige, 1994, pp. 305–309.

[17] R. Wu et al., “Cognitive modelling for predicting examinee performance,” 2015.

[18] R. I. John and P. R. Innocent, “Modeling uncertainty in clinical diagnosis using fuzzy logic,”

IEEE Transactions on Systems, Man, and Cybernetics, Part B (Cybernetics), vol. 35, no. 6, pp.

1340–1350, 2005.

[19] J. Yu, M. Tan, H. Zhang, D. Tao, and Y. Rui, “Hierarchical deep click feature prediction for

fine-grained image recognition,” IEEE transactions on pattern analysis and machine

intelligence, 2019.

[20] J. Zhang, J. Yu, and D. Tao, “Local deep-feature alignment for unsupervised dimension

reduction,” IEEE transactions on image processing, vol. 27, no. 5, pp. 2420–2432, 2018.

[21] Q. Li et al., “Early transmission dynamics in Wuhan, China, of novel coronavirus–infected

pneumonia,” New England journal of medicine, 2020.

[22] C. Huang et al., “Clinical features of patients infected with 2019 novel coronavirus in Wuhan,

China,” The lancet, vol. 395, no. 10223, pp. 497–506, 2020.

[23] W. G. Carlos, C. S. Dela Cruz, B. Cao, S. Pasnick, and S. Jamil, “Novel Wuhan (2019-nCoV)

Coronavirus.,” Am J Respir Crit Care Med, pp. P7–P8, 2020.

[24] W. Guan et al., “Clinical characteristics of coronavirus disease 2019 in China,” New England

journal of medicine, vol. 382, no. 18, pp. 1708–1720, 2020.

[25] F. Shan et al., “Lung infection quantification of COVID-19 in CT images with deep learning,”

arXiv preprint arXiv:2003.04655, 2020.

[26] F. Jiang, L. Deng, L. Zhang, Y. Cai, C. W. Cheung, and Z. Xia, “Review of the clinical

characteristics of coronavirus disease 2019 (COVID-19),” Journal of general internal

medicine, vol. 35, no. 5, pp. 1545–1549, 2020.

[27] M. Nour, Z. Cömert, and K. Polat, “A novel medical diagnosis model for COVID-19 infection

detection based on deep features and Bayesian optimization,” Applied Soft Computing, vol. 97,

p. 106580, 2020.

[28] N. Aydin and G. Yurdakul, “Assessing countries’ performances against COVID-19 via

WSIDEA and machine learning algorithms,” Applied Soft Computing, vol. 97, p. 106792,

2020.

[29] G. Marques, D. Agarwal, and I. de la Torre Díez, “Automated medical diagnosis of COVID-19

through EfficientNet convolutional neural network,” Applied soft computing, vol. 96, p.

106691, 2020.

[30] M. A. Mohammed et al., “Benchmarking methodology for selection of optimal COVID-19

diagnostic model based on entropy and TOPSIS methods,” Ieee Access, vol. 8, pp. 99115–

99131, 2020.

[31] B. B. Hazarika and D. Gupta, “Modelling and forecasting of COVID-19 spread using waveletcoupled

random vector functional link networks,” Applied Soft Computing, vol. 96, p. 106626,

2020.

[32] R. Sameni, “Mathematical modeling of epidemic diseases; a case study of the COVID-19

coronavirus,” arXiv preprint arXiv:2003.11371, 2020.

[33] M. Ahmadi, A. Sharifi, S. Dorosti, S. J. Ghoushchi, and N. Ghanbari, “Investigation of

effective climatology parameters on COVID-19 outbreak in Iran,” Science of the total

environment, vol. 729, p. 138705, 2020.

[34] Y. Zhu and Y. Q. Chen, “On a statistical transmission model in analysis of the early phase of

COVID-19 outbreak,” Statistics in biosciences, vol. 13, no. 1, pp. 1–17, 2021.

[35] P. Boldog, T. Tekeli, Z. Vizi, A. Dénes, F. A. Bartha, and G. Röst, “Risk assessment of novel

coronavirus COVID-19 outbreaks outside China,” Journal of clinical medicine, vol. 9, no. 2, p.

571, 2020.

[36] C. Yang and J. Wang, “A mathematical model for the novel coronavirus epidemic in Wuhan,

China,” Mathematical biosciences and engineering: MBE, vol. 17, no. 3, p. 2708, 2020.

[37] C.-C. Zhu and J. Zhu, “Spread trend of COVID-19 epidemic outbreak in China: using

exponential attractor method in a spatial heterogeneous SEIQR model,” Mathematical

Biosciences and Engineering, vol. 17, no. 4, pp. 3062–3087, 2020.

[38] M. A. Shereen, S. Khan, A. Kazmi, N. Bashir, and R. Siddique, “COVID-19 infection:

Emergence, transmission, and characteristics of human coronaviruses,” Journal of advanced

research, vol. 24, pp. 91–98, 2020.

[39] H.-Y. Tian, “2019-nCoV: new challenges from coronavirus,” Zhonghua yu fang yi xue za zhi

[Chinese journal of preventive medicine], vol. 54, pp. E001–E001, 2020.

[40] G. Li and E. De Clercq, “Therapeutic options for the 2019 novel coronavirus (2019-nCoV),”

Nature reviews Drug discovery, vol. 19, no. 3, pp. 149–150, 2020.